These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13248555)

  • 1. Formation of specific antibodies in rabbits immunized with serum from patients with disseminated lupus erythematosus.
    LOW B; ZETTERSTROM R
    Acta Pathol Microbiol Scand; 1955; 36(6):571-5. PubMed ID: 13248555
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response.
    McClain MT; Lutz CS; Kaufman KM; Faig OZ; Gross TF; James JA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3551-6. PubMed ID: 14988508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
    Nagel J; Saxne T; Geborek P; Bengtsson AA; Jacobsen S; Svaerke Joergensen C; Nilsson JÅ; Skattum L; Jönsen A; Kapetanovic MC
    Lupus; 2017 Sep; 26(10):1072-1081. PubMed ID: 28420056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.
    Yamauchi Y; Litwin A; Adams L; Zimmer H; Hess EV
    J Clin Invest; 1975 Oct; 56(4):958-69. PubMed ID: 808562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on antibodies to poly(ADP-ribose) in rabbits and patients with systemic lupus erythematosus.
    Kanai Y; Sugimura T
    Immunology; 1981 May; 43(1):101-10. PubMed ID: 7251045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent data on the L.E. phenomenon and on antibodies in disseminated lupus erythematosus].
    SELIGMANN M
    Presse Med (1893); 1961 Sep; 69():1643-6. PubMed ID: 13749888
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of vaccination of patients with systemic lupus erythematosus.
    Abu-Shakra M
    Lupus; 2009 Nov; 18(13):1205-8. PubMed ID: 19880569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases.
    ASHERSON GL
    Br J Exp Pathol; 1959 Jun; 40(3):209-15. PubMed ID: 13662525
    [No Abstract]   [Full Text] [Related]  

  • 9. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments.
    Poole BD; Gross T; Maier S; Harley JB; James JA
    J Autoimmun; 2008 Dec; 31(4):362-71. PubMed ID: 18849143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus.
    McDonald E; Jarrett MP; Schiffman G; Grayzel AI
    J Rheumatol; 1984 Jun; 11(3):306-8. PubMed ID: 6737372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of leukocyte agglutinating antibodies and thrombocytic antibodies in a case of acute disseminated lupus erythematosus.
    MULLER W; RADOJICIC B
    Klin Wochenschr; 1956 Jun; 34(21-22):577-81. PubMed ID: 13347017
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-leukocytic antibodies of disseminated lupus erythematosus].
    SELIGMANN M
    Acta Haematol; 1960; 24():81-92. PubMed ID: 13749887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of the Haserick factor by rabbit immune serum against human lupus erythematosus serum. Disseminated lupus erythematosus. Clinical serology].
    DEL REY CALERO J
    Laboratorio; 1960 Oct; 30():301-7. PubMed ID: 13721372
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes.
    Stastny P; Ziff M
    Clin Exp Immunol; 1971 Apr; 8(4):543-50. PubMed ID: 5103550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to influenza immunization in patients with systemic lupus erythematosus.
    Mercado U
    J Rheumatol; 2003 Oct; 30(10):2295; author reply 2295-6. PubMed ID: 14528534
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
    J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to denatured desoxyribonucleic acid in a lupus erythematosus serum.
    STOLLAR D; LEVINE L
    J Immunol; 1961 Oct; 87():477-84. PubMed ID: 13917427
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reactions among variously denatured or degraded desoxyribonucleic acids and the anti-desoxyribonucleic acid antibodies in the blood of patients with disseminated lupus erythematosus].
    BARBU E; SELIGMANN M; JOLY M
    Ann Inst Pasteur (Paris); 1960 Nov; 99():695-707. PubMed ID: 13686844
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural antibodies to procaine amide.
    Russell AS; Ziff M
    Clin Exp Immunol; 1968 Nov; 3(9):901-9. PubMed ID: 5751875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice.
    James JA; Harley JB
    J Immunol; 1998 Jan; 160(1):502-8. PubMed ID: 9552009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.